Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. products
  3. romania
  4. genomics redefines the boundaries of fungal genomics
Show results for

Refine by
Locations
Back to All Locations

  • Europe
  • Romania
Brands

  • amoydx

Amoydx Genomics Redefines The Boundaries Of Fungal Genomics Equipment & Supplies In In Romania

4 equipment items found
Available In RomaniaNear Romania

AmoyDx - Pan Lung Cancer PCR Panel

AmoyDx - Pan Lung Cancer PCR Panel

Manufactured by:Amoy Diagnostics Co., Ltd.   based inXiamen, CHINA
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in NSCLC for EGFR, HER2, KRAS and BRAF genes are respectively 10-50%, 1-4%, 5-25% and 1-2%. About 3-7%, 1%, 1%, 0.12%, 0.02%, 0.08% of NSCLC patients have gene fusions in ALK, ROS1, RET, NTRK1, NTRK2 and ...
CONTACT SUPPLIER

AmoyDx - Model PIK3CA - Mutation Detection Kit

AmoyDx - Model PIK3CA - Mutation Detection Kit

Manufactured by:Amoy Diagnostics Co., Ltd.   based inXiamen, CHINA
The phosphoinositide-3 -kinase catalytic alpha (PIK3CA) gene produces the p110 alpha (pl 10a) protein, which is one subunit of an enzyme called phosphatidylinositol 3-kinase (PI3K). PI3K plays a key role ofPI3K/Akt signaling pathway in numerous cellular processes critical for cancer progression, including metabolism, growth, survival, and motility. Somatic mutations in the PIK3CA gene are found ...
CONTACT SUPPLIER

AmoyDx - Multi-Gene Mutations Detection Kit

AmoyDx - Multi-Gene Mutations Detection Kit

Manufactured by:Amoy Diagnostics Co., Ltd.   based inXiamen, CHINA
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in patients with NSCLC for the EGFR gene is 10~35%, for KRAS 15?25%, for BRAF1-4%, for NRAS is 1%, for HER2 2-4%, and for PIK3CA 1-3%. About 3-7% of NSCLC patients have gene fusion in ALK, 2% in ROS1, and 1% ...
CONTACT SUPPLIER

AmoyDx - Handle HRR NGS Panel

AmoyDx - Handle HRR NGS Panel

Manufactured by:Amoy Diagnostics Co., Ltd.   based inXiamen, CHINA
The Homologous Recombination Repair (HRR) pathway plays an important role in double strand break, which is the major cause of cancer development. It has been demonstrated that loss of function of HRR genes (e.g. BRCA1, BRCA2, PALB2) and homologous recombination deficiency (HRD) will cause a higher risk of developing cancer, and patients with HRR gene mutations showed higher response to PARPi and ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About

Channels

Solutions

  • Industry Products
  • Industry Software
  • Industry Training
  • Industry Services
  • Industry Applications

Latest

  • Industry News
  • Industry Events

Publications

  • Industry Articles
  • Industry Books
  • Industry Magazines
  • Industry Downloads
  • Industry Videos

Companies

  • Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT